Cargando…
CD82 protects against glaucomatous axonal transport deficits via mTORC1 activation in mice
Glaucoma is a leading cause of irreversible blindness worldwide and is characterized by progressive optic nerve degeneration and retinal ganglion cell loss. Axonal transport deficits have been demonstrated to be the earliest crucial pathophysiological changes underlying axonal degeneration in glauco...
Autores principales: | Ye, Meng, Huang, Jingqiu, Mou, Qianxue, Luo, Jing, Hu, Yuanyuan, Lou, Xiaotong, Yao, Ke, Zhao, Bowen, Duan, Qiming, Li, Xing, Zhang, Hong, Zhao, Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665930/ https://www.ncbi.nlm.nih.gov/pubmed/34897284 http://dx.doi.org/10.1038/s41419-021-04445-6 |
Ejemplares similares
-
TBK1 Knockdown Alleviates Axonal Transport Deficits in Retinal Ganglion Cells Via mTORC1 Activation in a Retinal Damage Mouse Model
por: Ye, Meng, et al.
Publicado: (2023) -
Modulation of Sirt1-mTORC1 Pathway in Microglia Attenuates Retinal Ganglion Cell Loss After Optic Nerve Injury
por: Mou, Qianxue, et al.
Publicado: (2021) -
Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition
por: Yao, Ke, et al.
Publicado: (2023) -
VIP Stabilizes the Cytoskeleton of Schlemm's Canal Endothelia via Reducing Caspase-3 Mediated ZO-1 Endolysosomal Degradation
por: Lou, Xiaotong, et al.
Publicado: (2021) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)